Cargando…
Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway
Ovarian cancer (OVCA) patients often develop tolerance to standard platinum therapy that accounts for extensive treatment failures. Cisplatin resistant OVCA cells (cis-R) display enhanced survival mechanisms to cope with therapeutic stress. In these cells, increased autophagy process assists in chem...
Autores principales: | Kulshrestha, Arpita, Katara, Gajendra K., Ibrahim, Safaa A., Riehl, Valerie, Sahoo, Manoranjan, Dolan, James, Meinke, Kyle W., Pins, Michael R., Beaman, Kenneth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463777/ https://www.ncbi.nlm.nih.gov/pubmed/31057611 http://dx.doi.org/10.1155/2019/2343876 |
Ejemplares similares
-
Cancer‐associated V‐ATPase induces delayed apoptosis of protumorigenic neutrophils
por: Ibrahim, Safaa A., et al.
Publicado: (2020) -
Cancer derived peptide of vacuolar ATPase ‘a2’ isoform promotes neutrophil migration by autocrine secretion of IL-8
por: Ibrahim, Safaa A., et al.
Publicado: (2016) -
Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression
por: Ibrahim, Safaa A., et al.
Publicado: (2015) -
Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells
por: Sahoo, Manoranjan, et al.
Publicado: (2018) -
Vacuolar ATPase ‘a2’ isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer
por: Kulshrestha, Arpita, et al.
Publicado: (2015)